(OLMA) Olema Pharmaceuticals - Performance -57.2% in 12m
OLMA performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-74.49%
#112 in Peer-Group
Rel. Strength
7.18%
#7146 in Stock-Universe
Total Return 12m
-57.17%
#142 in Peer-Group
Total Return 5y
-90.67%
#115 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 16.46 USD |
| 52 Week Low | 3.06 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 74.40 |
| Buy/Sell Signal +-5 | 0.36 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: OLMA (-57.2%) vs XBI (-6.2%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
2.94% | 73.2% | 77.8% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-9.16% | -5.32% | 147% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
2.99% | -0.49% | 36% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
1.6% | 32.8% | -4.82% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
3.29% | -6.6% | 1.14% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
17.1% | 57.4% | -4.19% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-3.2% | 58.3% | -9.25% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
5.64% | 38.5% | 15.2% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: OLMA vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for OLMA
| Total Return (including Dividends) | OLMA | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 12.84% | 3.53% | 5.22% |
| 3 Months | 36.42% | 9.10% | 16.86% |
| 12 Months | -57.17% | -6.17% | 14.81% |
| 5 Years | -90.67% | -24.21% | 111.83% |
| Trend Score (consistency of price movement) | OLMA | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 45.2% | 4.4% | 81% |
| 3 Months | 0.6% | 78.8% | 96.9% |
| 12 Months | -89.8% | -85.8% | 44.9% |
| 5 Years | -33.9% | -52.6% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th77.50 | 8.99% | 7.24% |
| 3 Month | %th75.00 | 25.04% | 16.73% |
| 12 Month | %th29.00 | -54.36% | -62.70% |
| 5 Years | %th42.50 | -86.36% | -95.01% |
FAQs
Does Olema Pharmaceuticals (OLMA) outperform the market?
No,
over the last 12 months OLMA made -57.17%, while its related Sector, the SPDR S&P Biotech (XBI) made -6.17%.
Over the last 3 months OLMA made 36.42%, while XBI made 9.10%.
Performance Comparison OLMA vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
OLMA vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -2% | 7.6% | -28.7% | -72% |
| US NASDAQ 100 | QQQ | -1.6% | 7.2% | -30% | -71% |
| German DAX 40 | DAX | -1% | 13.5% | -42.2% | -87% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -0.3% | 8.6% | -31.5% | -76% |
| Hongkong Hang Seng | HSI | -1% | 6.5% | -47.1% | -93% |
| India NIFTY 50 | INDA | 0.1% | 9.5% | -26.9% | -57% |
| Brasil Bovespa | EWZ | -4% | 4.6% | -55.4% | -69% |
OLMA vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -1.3% | 6.3% | -33.4% | -84% |
| Consumer Discretionary | XLY | -2.7% | 9.9% | -20.8% | -76% |
| Consumer Staples | XLP | -2.3% | 12.9% | -28.6% | -67% |
| Energy | XLE | -1.3% | 7.9% | -23.5% | -55% |
| Financial | XLF | -2.5% | 8.4% | -32.7% | -87% |
| Health Care | XLV | -0.7% | 10.5% | -20.8% | -53% |
| Industrial | XLI | -2.6% | 8.6% | -35.7% | -82% |
| Materials | XLB | -3.9% | 8.2% | -33.3% | -63% |
| Real Estate | XLRE | -1.8% | 11.6% | -26.4% | -70% |
| Technology | XLK | -2.1% | 4% | -31.8% | -69% |
| Utilities | XLU | -0.6% | 12.8% | -30.1% | -80% |
| Aerospace & Defense | XAR | -0.7% | 5.2% | -45.9% | -106% |
| Biotech | XBI | -1.6% | 9.3% | -14.7% | -51% |
| Homebuilder | XHB | -4.9% | 4.3% | -20.8% | -62% |
| Retail | XRT | -5% | 8.6% | -24.1% | -68% |
OLMA vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -2% | 5.26% | -18.9% | -50% |
| Natural Gas | UNG | 2.8% | 22.9% | -20.2% | -50% |
| Gold | GLD | 0.1% | 13.4% | -48.6% | -98% |
| Silver | SLV | -0.3% | 6.3% | -46.6% | -78% |
| Copper | CPER | -0.4% | 7.8% | -47.3% | -71% |
OLMA vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 1% | 10.2% | -24.2% | -56% |
| iShares High Yield Corp. Bond | HYG | -0.2% | 11.1% | -27.2% | -68% |